
Customize View

Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
There are no recently disclosed strategic alliances listed

Prior and Not Recently Disclosed Strategic Alliances
Strategic Alliance Name
Primary Industry
Source
Arbor Vita Corporation
Biotechnology
Key DevelopmentStrategic Alliances Oct-16-2006
Business Description: Arbor Vita Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of proteomic-based diagnostics and therapeutics to treat infectious diseases and cancer. It offers diagnostic solutions that include OncoE6 cervical test, a point-of-care test that analyzes cervical specimens for the cancer-causing oncoprotein; A/H7N9 Influenza Rapid Test to detect the NS1 protein antigen of influenza A/H7N9 virus from nasal swab specimens and viral cultures in patients untypeable for seasonal influenza A; OncoE6 oral test, detects elevated levels of cancer-causing HPV viral E6 oncoprotein; CoVisa IgG test, ELISA-based test for antibodies associated with coronavirus disease; and AV Avantage A/H5N1 Flu Test, a rapid test for the detection of the A/H5N1 influenza virus from throat and nasal swab specimens, and viral cultures. The company also produces a range of research reagents in the areas of monoclonal antibodies and PDZ proteomics. Arbor Vita Corporation was incorporated in 1998 and is based in Fremont, California.
*denotes proprietary relationship